Barry Kinzbrunner, MD, Executive Vice President, Chief Medical Officer, VITAS Corporation, speaks about ways for managed care organizations to reduce hospital readmissions.
Barry Kinzbrunner, MD, Executive Vice President, Chief Medical Officer, VITAS Corporation, speaks about ways for managed care organizations to reduce hospital readmissions with hospice and palliative care services.
“Better utilization of hospice services earlier in the course of illness would be an excellent way of improving end-of-life care and saving costs for the entire system,” says Dr. Kinzbrunner.
This video interview was performed on June 21, 2012, at the America's Health Insurance Plans Institute 2012 in Salt Lake City, UT.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More